QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 18 January 2005
doi: 10.1242/jcs.01661

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jcs.01661v1 118/3/623    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bazzoni, G. Articles by Dejana, E. Search for Related Content PubMed PubMed Citation Articles by Bazzoni, G. Articles by Dejana, E. Social Bookmarking                         What's this?

Expression of junctional adhesion molecule-A prevents spontaneous and random motility

¹ Laboratory of Systems Biology, Department of Immunology and Cell Biology, Istituto di Ricerche Farmacologiche Mario Negri, 20157 Milano, Italy
² Department of Vascular Biology, FIRC Institute of Molecular Oncology, 20139 Milano, Italy
³ Laboratory of Vascular Biology, Department of Immunology and Cell Biology, Istituto di Ricerche Farmacologiche Mario Negri, 20157 Milano, Italy
⁴ Department of Biomolecular and Biotechnological Sciences, School of Sciences, University of Milan, 20133 Milano, Italy

^* Author for correspondence (e-mail: bazzoni{at}marionegri.it)

Accepted 24 November 2004

Junctional adhesion molecule-A (JAM-A) is a cell-surface glycoprotein that localizes to intercellular junctions and associates with intracellular proteins via PSD95-Dlg-ZO1-binding residues. To define the functional consequences of JAM-A expression, we have produced endothelial cells from JAM-A-deficient mice. We report here that the absence of JAM-A enhanced spontaneous and random motility. In turn, the enhanced motility of JAM-A-negative cells was abrogated either on transfection of exogenous JAM-A or on treatment with inhibitors of glycogen synthase kinase-3ß (GSK-3ß). In addition, in JAM-A-positive cells, motility was enhanced on inactivation of protein kinase C (PKC), which is an inhibitor of GSK-3ß. Although these findings suggested that JAM-A might inhibit GSK-3ß, we found that expression per se of JAM-A did not change the levels of inactive GSK-3ß. Thus, JAM-A expression may regulate effectors of motility that are also downstream of the PKC/GSK-3ß axis. In support of this view, we found that JAM-A absence increased the number of actin-containing protrusions, reduced the stability of microtubules and impaired the formation of focal adhesions. Notably, all the functional consequences of JAM-A absence were reversed either on treatment with GSK-3ß inhibitors or on transfection of full-length JAM-A, but not on transfection of a JAM-A deletion mutant devoid of the PSD95-Dlg-ZO1-binding residues. Thus, by regulating cytoskeletal and adhesive structures, JAM-A expression prevents cell motility, probably in a PSD95-Dlg-ZO1-dependent manner.

Key words: Junction adhesion molecule, Motility, Glycogen Synthase kinase 3, PDZ domains, Microtubules, Focal adhesions

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				E. A. Severson, W. Y. Lee, C. T. Capaldo, A. Nusrat, and C. A. Parkos Junctional Adhesion Molecule A Interacts with Afadin and PDZ-GEF2 to Activate Rap1A, Regulate {beta}1 Integrin Levels, and Enhance Cell Migration Mol. Biol. Cell, April 1, 2009; 20(7): 1916 - 1925. [Abstract] [Full Text] [PDF]

				M. R. Cera, M. Fabbri, C. Molendini, M. Corada, F. Orsenigo, M. Rehberg, C. A. Reichel, F. Krombach, R. Pardi, and E. Dejana JAM-A promotes neutrophil chemotaxis by controlling integrin internalization and recycling J. Cell Sci., January 15, 2009; 122(2): 268 - 277. [Abstract] [Full Text] [PDF]

				E. A. Severson, L. Jiang, A. I. Ivanov, K. J. Mandell, A. Nusrat, and C. A. Parkos Cis-Dimerization Mediates Function of Junctional Adhesion Molecule A Mol. Biol. Cell, May 1, 2008; 19(5): 1862 - 1872. [Abstract] [Full Text] [PDF]

				Y. Sugano, M. Takeuchi, A. Hirata, H. Matsushita, T. Kitamura, M. Tanaka, and A. Miyajima Junctional adhesion molecule-A, JAM-A, is a novel cell-surface marker for long-term repopulating hematopoietic stem cells Blood, February 1, 2008; 111(3): 1167 - 1172. [Abstract] [Full Text] [PDF]

				P. T. Fok, K.-C. Huang, P. C. Holland, and J. Nalbantoglu The Coxsackie and Adenovirus Receptor Binds Microtubules and Plays a Role in Cell Migration J. Biol. Chem., March 9, 2007; 282(10): 7512 - 7521. [Abstract] [Full Text] [PDF]

				S. Nourshargh, F. Krombach, and E. Dejana The role of JAM-A and PECAM-1 in modulating leukocyte infiltration in inflamed and ischemic tissues J. Leukoc. Biol., October 1, 2006; 80(4): 714 - 718. [Abstract] [Full Text] [PDF]

				S. Liebner, U. Cavallaro, and E. Dejana The Multiple Languages of Endothelial Cell-to-Cell Communication Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1431 - 1438. [Abstract] [Full Text] [PDF]

				M. U. Naik and U. P. Naik Junctional adhesion molecule-A-induced endothelial cell migration on vitronectin is integrin {alpha}v{beta}3 specific J. Cell Sci., February 1, 2006; 119(3): 490 - 499. [Abstract] [Full Text] [PDF]

				C. Lamagna, P. Meda, G. Mandicourt, J. Brown, R. J.C. Gilbert, E. Y. Jones, F. Kiefer, P. Ruga, B. A. Imhof, and M. Aurrand-Lions Dual Interaction of JAM-C with JAM-B and {alpha}M{beta}2 Integrin: Function in Junctional Complexes and Leukocyte Adhesion Mol. Biol. Cell, October 1, 2005; 16(10): 4992 - 5003. [Abstract] [Full Text] [PDF]

				M.-T. Huang, J. C. Mason, G. M. Birdsey, V. Amsellem, N. Gerwin, D. O. Haskard, A. J. Ridley, and A. M. Randi Endothelial intercellular adhesion molecule (ICAM)-2 regulates angiogenesis Blood, September 1, 2005; 106(5): 1636 - 1643. [Abstract] [Full Text] [PDF]